Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3798960rdf:typepubmed:Citationlld:pubmed
pubmed-article:3798960lifeskim:mentionsumls-concept:C0237401lld:lifeskim
pubmed-article:3798960lifeskim:mentionsumls-concept:C0030016lld:lifeskim
pubmed-article:3798960lifeskim:mentionsumls-concept:C0031437lld:lifeskim
pubmed-article:3798960lifeskim:mentionsumls-concept:C0017725lld:lifeskim
pubmed-article:3798960lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:3798960pubmed:issue12lld:pubmed
pubmed-article:3798960pubmed:dateCreated1987-2-11lld:pubmed
pubmed-article:3798960pubmed:abstractTextThe acetylator phenotype was determined for 142 Nigerian adults by administering sulphamethazine (40 mg/kg body wt) and analysing six hour urines for free and acetylated drug. Of these 142 subjects, 21 (14.8%) had no red cell glucose 6-phosphate dehydrogenase activity, 35 (24.6%) had partial activity and 86 (60.56%) had normal activity. The percentage of slow acetylators among the three groups was 38.1%, 40% and 40.7% respectively. The differences between the three groups were not statistically significant. However, individuals with no red cell glucose 6-phosphate dehydrogenase activity and who are also slow acetylators may be more sensitive to the effects of drugs like sulphamethazine, dapsone and isoniazid.lld:pubmed
pubmed-article:3798960pubmed:languageenglld:pubmed
pubmed-article:3798960pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3798960pubmed:citationSubsetIMlld:pubmed
pubmed-article:3798960pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3798960pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3798960pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3798960pubmed:statusMEDLINElld:pubmed
pubmed-article:3798960pubmed:monthDeclld:pubmed
pubmed-article:3798960pubmed:issn0049-8254lld:pubmed
pubmed-article:3798960pubmed:authorpubmed-author:FrenchM RMRlld:pubmed
pubmed-article:3798960pubmed:authorpubmed-author:JeyakumarL...lld:pubmed
pubmed-article:3798960pubmed:issnTypePrintlld:pubmed
pubmed-article:3798960pubmed:volume16lld:pubmed
pubmed-article:3798960pubmed:ownerNLMlld:pubmed
pubmed-article:3798960pubmed:authorsCompleteYlld:pubmed
pubmed-article:3798960pubmed:pagination1129-32lld:pubmed
pubmed-article:3798960pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3798960pubmed:meshHeadingpubmed-meshheading:3798960-...lld:pubmed
pubmed-article:3798960pubmed:meshHeadingpubmed-meshheading:3798960-...lld:pubmed
pubmed-article:3798960pubmed:meshHeadingpubmed-meshheading:3798960-...lld:pubmed
pubmed-article:3798960pubmed:meshHeadingpubmed-meshheading:3798960-...lld:pubmed
pubmed-article:3798960pubmed:meshHeadingpubmed-meshheading:3798960-...lld:pubmed
pubmed-article:3798960pubmed:meshHeadingpubmed-meshheading:3798960-...lld:pubmed
pubmed-article:3798960pubmed:meshHeadingpubmed-meshheading:3798960-...lld:pubmed
pubmed-article:3798960pubmed:meshHeadingpubmed-meshheading:3798960-...lld:pubmed
pubmed-article:3798960pubmed:meshHeadingpubmed-meshheading:3798960-...lld:pubmed
pubmed-article:3798960pubmed:year1986lld:pubmed
pubmed-article:3798960pubmed:articleTitleAcetylator phenotype among individuals with glucose 6-phosphate dehydrogenase variants.lld:pubmed
pubmed-article:3798960pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3798960lld:pubmed